Vestal Point Capital’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-525,000	Closed	-$6.12M	–	77
2024 Q4	$6.12M	Buy	+525,000	New	+$6.12M	0.36%	51